Jorge Matias-Guiu
Overview
Explore the profile of Jorge Matias-Guiu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
156
Citations
1744
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Valles-Salgado M, Matias-Guiu J, Delgado-Alvarez A, Delgado-Alonso C, Gil-Moreno M, Valiente-Gordillo E, et al.
J Clin Med
. 2024 Aug;
13(16).
PMID: 39200837
: We aimed to evaluate and compare the diagnostic capacity of five cognitive screening tests for the diagnosis of mild cognitive impairment (MCI) in patients consulting by memory loss. :...
12.
Diez-Cirarda M, Yus-Fuertes M, Polidura C, Gil-Martinez L, Delgado-Alonso C, Delgado-Alvarez A, et al.
Psychiatry Res
. 2024 Aug;
340:116113.
PMID: 39146616
The main objective was to evaluate structural and functional connectivity correlates of fatigue in post-COVID syndrome, and to investigate the relationships with an objective measure of mental fatigue and with...
13.
Valles-Salgado M, Gil-Moreno M, Cid R, Delgado-Alvarez A, Ortega-Madueno I, Delgado-Alonso C, et al.
Front Psychol
. 2024 Jul;
15:1373541.
PMID: 38988382
Introduction: Timely and accurate diagnosis of the earliest manifestations of Alzheimer's disease (AD) is critically important. Cognitive challenge tests such as the Loewenstein Acevedo Scales for Semantic Interference and Learning...
14.
Vidorreta-Ballesteros L, Matias-Guiu J, Delgado-Alvarez A, Delgado-Alonso C, Valles-Salgado M, Cuevas C, et al.
Mult Scler Relat Disord
. 2024 May;
87:105678.
PMID: 38728960
Background: We aimed to investigate the characteristics of cognitive impairment in older people with multiple sclerosis (MS). Methods: Cross-sectional study that included participants that were examined with a common and...
15.
Delgado-Alonso C, Delgado-Alvarez A, Diez-Cirarda M, Oliver-Mas S, Cuevas C, Montero-Escribano P, et al.
Sci Rep
. 2024 Apr;
14(1):9806.
PMID: 38684843
Post-COVID condition (PCC) and multiple sclerosis (MS) share some clinical and demographic features, including cognitive symptoms and fatigue. Some pathophysiological mechanisms well-known in MS, such as autoimmunity, neuroinflammation and myelin...
16.
Fernandez-Beltran L, Ali Z, Larrad-Sanz A, Lopez-Carbonero J, Godoy-Corchuelo J, Jimenez-Coca I, et al.
Sci Rep
. 2024 Feb;
14(1):2671.
PMID: 38302474
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by significant metabolic disruptions, including weight loss and hypermetabolism in both patients and animal models. Leptin, an adipose-derived hormone, displays...
17.
Leon-Moreno L, Reza-Zaldivar E, Hernandez-Sapiens M, Villafana-Estarron E, Garcia-Martin M, Ojeda-Hernandez D, et al.
Biomolecules
. 2024 Jan;
14(1).
PMID: 38275749
One of the main concerns related to SARS-CoV-2 infection is the symptoms that could be developed by survivors, known as long COVID, a syndrome characterized by persistent symptoms beyond the...
18.
Matias-Guiu J, Gonzalez-Rosa J, Hernandez M, Martinez-Gines M, Portoles A, Perez-Macias N, et al.
BMJ Open
. 2024 Jan;
14(1):e078661.
PMID: 38176857
Introduction: Fatigue is one of the most disabling symptoms of multiple sclerosis (MS), and effective treatments are lacking. Amantadine is one of the most used treatments, although its efficacy is...
19.
Cabrera-Martin M, Nespral P, Valles-Salgado M, Bascunana P, Delgado-Alonso C, Delgado-Alvarez A, et al.
Front Psychol
. 2023 Nov;
14:1273608.
PMID: 38034292
Introduction: The Addenbrooke's Cognitive Examination III (ACE-III) is a brief test useful for neuropsychological assessment. Several studies have validated the test for the diagnosis of Alzheimer's disease (AD) and frontotemporal...
20.
Delgado-Alvarez A, Delgado-Alonso C, Valles-Salgado M, Gil-Moreno M, Fernandez-Romero L, Matias-Guiu J, et al.
J Alzheimers Dis
. 2023 Nov;
96(3):1231-1241.
PMID: 37927267
Background: Cross-Cultural Dementia Screening (CCD), Rowland Universal Dementia Assessment Scale (RUDAS), and European Cross-cultural Neuropsychological Test Battery (CNTB) are three novel neuropsychological instruments developed from a cross-cultural perspective to reduce...